Ironwood Pharmaceuticals ...

NASDAQ: IRWD · Real-Time Price · USD
1.07
-0.02 (-1.83%)
At close: Aug 14, 2025, 3:59 PM
1.02
-5.12%
After-hours: Aug 14, 2025, 07:31 PM EDT

Ironwood Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
351.41M 442.74M 410.6M 413.75M
Cost of Revenue
2.01M 1.57M 1.42M 1.52M
Gross Profit
343.86M 442.74M 409.18M 412.23M
Operating Income
93.12M -945.43M 250.34M 232.26M
Interest Income
4.47M 18.97M 9.5M 726K
Pretax Income
65.2M -948.07M 252.42M 200.66M
Net Income
880K -1B 175.06M 528.45M
Selling & General & Admin
144.27M 158.31M 115.99M 111.13M
Research & Development
111.42M 116.08M 44.27M 70.41M
Other Expenses
-4.96M 1.11B -1.42M -70.45M
Operating Expenses
250.73M 1.39B 158.84M 111.09M
Interest Expense
33.03M 21.63M 7.6M 31.15M
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
258.29M 1.39B 160.26M 181.49M
Income Tax Expense
64.32M 83.49M 77.36M -327.79M
Shares Outstanding (Basic)
159.08M 155.44M 154.37M 162.25M
Shares Outstanding (Diluted)
160.08M 155.44M 186.31M 164.42M
EPS (Basic)
0.01 -6.45 1.13 3.26
EPS (Diluted)
0.01 -6.45 0.96 3.21
EBITDA
100.24M -924.87M 261.44M 233.33M
EBIT
98.23M -926.44M 260.02M 231.81M
Depreciation & Amortization
2.01M 1.57M 1.42M 1.52M